Coherus Biosciences | Aktywa





Aktywa Zmiana Data
AbbVie USD 28.54B 722M 2025-09
Acadia Pharmaceuticals USD 1.08B 115.87M 2025-09
Akebia Therapeutics USD 258.34M 23.68M 2025-09
ALKERMES USD 1.74B 106.38M 2025-09
Alnylam Pharmaceuticals USD 3.95B 309.11M 2025-09
Amarin USD 628.33M 21.52M 2025-09
Amgen USD 29.06B 1.17B 2025-12
Baxter International USD 6.93B 184M 2025-09
Biogen USD 8.97B 37.5M 2025-12
BioMarin Pharmaceutical USD 3.85B 49.21M 2025-09
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Coherus Biosciences USD 460.96M 80.75M 2025-09
Eli Lilly USD 62.07B 12.22B 2025-09
Fujifilm JPY 1.72T 120.76B 2025-12
Gilead Sciences USD 18.84B 4.12B 2025-09
Ironwood Pharmaceuticals USD 273.84M 82.09M 2025-09
Merck USD 47.56B 10.49B 2025-09
Myriad Genetics USD 344.8M 60.5M 2025-09
Pacira USD 562.75M 182.86M 2025-09
Perrigo USD 2.88B 264.2M 2025-09
Pfizer USD 46.92B 3.22B 2025-09
PTC Therapeutics USD 2.01B 265.07M 2025-09
Regeneron Pharmaceuticals USD 18.02B 41.2M 2025-12
Sarepta Therapeutics USD 2.72B 65.32M 2025-09
Teva Pharmaceutical Industries USD 13.95B 1.21B 2025-12
Vertex Pharmaceuticals USD 10.57B 141.7M 2025-09
Xencor USD 518.44M 5.29M 2025-09
Zoetis USD 6.58B 660M 2025-09


Coherus Biosciences Aktywa - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Feb 2026.